Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Nobel Peace Prize winner Machado vows to bring award back to Venezuela
1 dead as rain floods Gaza tents, medics say
US seizes sanctioned oil tanker off coast of Venezuela, Trump says
Australian leader defends social media ban as teens flaunt workarounds
Bangladesh to announce national election date on December 11
